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The aim ofthis study was to test the efficacy of 
thermal ultrasound therapy as a treatment for 
severe post partum breast engorgement. A 
randomised double-blind, placebo-controlled 
trial was conducted on 197 breasts. Two 
ultrasound machines of identical appearance 
were used. One was working normally, the 
other had the crystal replaced with a resistor 
producing surface heat only. Assessment of 
effectiveness was subjective, using visual 
analogue scales for pain and hardness, and 
objective, using tonometry. Results indicate 
that both the true and sham machines were 
effective in reducing subjectively perceived pain 
and hardness. However, the results ofthisstudy 
show that the effect cannot be attributed to the 
ultrasound component. 
[McLachlan Z, Milne EJ, Lumley J, Walker BL: 
Ultrasound treatment for breast engorgement: 
A randomised double blind trial. Australian 
Journal of Physiotherapy 37: 23-29, 1991] 
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ORIGINAl ARTIClE 
Ultrasound treatment for 
breast engorgement: A 
randomised double blind trial 
ost partum breast engorgement is 
a common problem. In most 
cases, the pain is mild and the 
condition is short lived, resolving 
rapidly as demand feeding is 
established. Sometimes the condition 
becomes severe and painful with 
blocked milk ducts, feeding difficulties 
and a depressed milk ejection reflex. 
In 1981, anecdotal reporting 
suggested that treatment with 
ultrasound was beneficial in severe 
breast engorgement (Shellshear 1981). 
Following a second report (Semmler 
1982), the treatment was implemented 
at the Queen Victoria Medical Centre 
(now the Monash Medical Centre) in 
1982. Women receiving the treatment, 
physiotherapists, midwives and 
obstetricians all found it to be clinically 
successful (Milne 1983). However, no 
clinical trials to evaluate its 
effectiveness had been attempted. 
Increasing discussion about the 
widespread use of poorly evaluated 
therapies led to the decision in 1985 to 
make this treatment available only 
within a randomised trial. It was clear 
that the non-ultrasound components of 
the treatment (warmth, rest, massage, 
attention, emotional, practical and 
informational support) might be 
making a substantial contribution to its 
perceived effectiveness. The trial was 
therefore designed to compare two 
apparently identical treatments, only 
one of which involved ultrasonic 
energy. 
Method 
Equipment 
Two new ultrasound machines of 
identical appearance were used 
Medtron model P300 (Metronex 
Engineering - Bell and Associates). 
The control machine had the crystal 
removed and replaced with a resistor to 
produce surface heat only, with the 
working dial responding to the 
intensity control. As the intensity 
control was turned up, the working 
dial showed a corresponding increase 
in thermal output. 
The trial machine was calibrated at 
six-monthly intervals by the 
manufacturer using appropriate 
calibration standards and a new crystal 
was used after 12 months. The serial 
numbers of the machines were covered 
and the machines were labelled A and 
B. Labels were changed weekly by the 
head of the department who had no 
role in the ultrasound treatment and 
did not hold the trial log book. She was 
provided with a predetermined 
randomised schedule for the labels. 
A digital tonometer was designed 
specifically for the project in order to 
have an objective measure of breast 
hardness. This was a spring-loaded, 
rounded probe of 8mm diameter, 
protruding lcm from a flat plate. 
When applied to the breast, the 
movement of the probe against the 
spring was proportional to the 
hardness 
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Tahl., 1. 
Comparability of the three treatment groups 
Breast treatment 
Ultrasound Ultrasound Sham [2] 
[2] [1] 
11 % Sham [1] 
Trial participants 109 {100] 22 64 23 
Primiparous 51 [46.8] 8 32 11 
Maternal age: 
<19 4 [3.7] 0 4 0 
20-29 35 [32.1 ] 6 16 13 
30-39 65 {59.6] 16 41 8 
40+ 5 [4.6] 0 3 2 
Multiple gestation 5 [4.6] 1 3 1 
Pre-term delivery: 
<37 weeks 32 [29.4] 4 21 7 
Patient category; 
Public 34 {31.2] 4 19 11 
Private. 75 [68.8] 18 45 12 
Drugs: 
Analgesics 73 [67.0] 14 44 15 
Antibiotics 8 [7.3] 3 4 1 
Syntocinon 11 [1O.1J 0 10 1 
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of the breast. The movement of the 
probe was linked mechanically to a 
linear resistor and the resistance 
measured by a digital multimeter. The 
linearity and long-term stability were 
checked monthly to ensure a constant 
response. The probe was calibrated by 
applying it to an artificial breast 
comprised of a plastic fluid-filled 
chamber in which the pressure was 
altered in steps to simulate the range of 
hardness of the breast. 
Entry and exclusion criteria 
The entry criterion for the trial was 
referral to the physiotherapists for 
treatment of breast engorgement. 
Some women had additional breast 
problems (e.g. sore nipples) and a few 
were, in fact, referred post partum with 
breast lumps. Women weree.x;cluded if 
their spoken or written English was 
insufficient for informed consent or if 
they had previously received breast 
(silicone) implants. Most referrals came 
from the lactation consultant, but the 
charge nurse of the post partum ward 
and the obstetricians could also refer 
women. 
On referral, the physiotherapist 
discussed the trial with each woman 
and provided a plain language 
information sheet before seeking 
written consent. After this, the 
woman's name was given to the clerical 
officer who held the trial log book. She 
informed the treating physiotherapist 
which machine (A or B) would be used 
for each breast according to a balanced 
block randomisation sequence which 
had been prepared in advance. 
Since each woman might have 
problems with one or two breasts, each 
individual breast, rather than each 
individual woman, was randomised to 
treatment A or treatment B. 
Treatment of an individual breast was 
always by the same machine. 
Procedure 
Treatment was timed to take place an 
hour before breast feeding or 
expression, but demand feeding often 
made this interval difficult to judge. 
Before treatment, the physiotherapist 
recorded data on the birth and feeding 
history and the woman filled in the 
horizontal visual analogue scales (Scott 
and Huskisson 1976). These were 
straight lines· 1 OOrum long with no 
gradations marked. For the pain scale 
the left end was marked "no pain" and 
the right end "pain as bad as it could 
be" . For the hardness scale the left end 
was labelled "soft" and the right end 
"as hard as it could be". 
Separate scales were completed for 
each breast and it was emphasised that 
there were no right or wrong 
measures. Then, with the woman in a 
comfortable supine position, a pillow 
under her head and hands behind her 
head, a black dot was marked on each 
quadrant of the breast, and four 
tonometer readings taken around each 
dot. 
Treatment by the physiotherapist 
with thermal (continuous) ultrasound 
was given using aquasonic ultrasound 
transmission gel as the coupling agent. 
As in all therapeutic ultrasound 
treatments, the intensity was adjusted 
to give a comfortable warmth and the 
treatment application head was 
massaged over the breast towards the 
areola. Firmer pressure was used on 
the inwards stroke. 'The duration of 
treatment ranged from eight minutes 
for a breast of A cup size to 15 minutes 
for a breast ofDD or greater cup size. 
Following treatment, visual analogue 
scales for pain and hardness were again 
completed for each breast. The women 
could see their previous ratings while 
they did this. The tonometer readings 
were repeated and the women 
encouraged to feed their infants (or 
express milk) as soon as possible. 
Women were reassessed each 
morning and treated again if necessary. 
Repeat treatments were included in the 
data collection. Indications for further 
treatment were poor milk flow, 
persistent areas of redness or persistent 
pain and hardness of the breast. 
Occasionally, women were treated 
twice in one day if their symptoms 
were severe. The number of 
treatments given ranged from one to 
six and a final set of measures (both 
analogue scales and tonometry) was 
taken approximately 24 hours after the 
final treatment. 
An obstetric registrar collected 
additional medical data including a 
family history of breast cancer, during 
the treatment course. 
Design and analysis 
The trial was designed to detect a 
reduction of 25 per cent in ratings of 
pain and hardness with ultrasound or a 
25 per cent difference in ratings 
between ultrasound and sham treated 
breasts (n= 0.05, ~ = 0.20). 
The treatment given to each breast 
(ultrasound or sham) was decoded 
from the trial log book and machine 
allocation schedules after completion 
of the trial. Data were analysed using a 
statistical software package (EPILOG). 
Means and differences were compared 
using paired or unpaired t-tests as 
appropriate. Proportions were 
compared using the Chi-square test. 
Duration of breastfeeding was assessed 
in a survival analysis using log-rank 
statistics. Comparisons involved paired 
and unpaired t-tests. Chi-square tests 
and life-table analyses were conducted 
with log-ranked statistics. 
Results 
During the 30 months of 
recruitment, 111 women were referred 
for treatment of breast engorgement, 
this being less than 2 per cent of all 
those giving birth in the hospital. Two 
refused to participate in the trial. The 
mean interval between birth and the 
first treatment was 82 hours. 
Since each breast, rather than each 
woman, was atrial "subject';, there 
were three-groups. The first was 
women in whom both breasts received 
treatment with ultrasound (22). The 
second was WOmen in whom both 
breaSts received the sham treatment 
(23).1n the third group, 64 women 
were combined, in whom one breast 
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received ultrasound and one received 
sham treatment (43) or women in 
whom only one breast was treated 
either with sham or with ultrasound 
(21). Table 1 summarises 
sociodemographic, obstetric and 
paediatric data on the participants and 
shows that the randomisation 
procedures produced three comparable 
groups prior to treatment. 
The age range of women in the trial 
was 16 to 42 years with an average age 
of 30.4 years. Fewer than half were 
primiparous. The proportion of 
women with a pre-term infant was 
twice that in the hospital population 
and 36 per cent of participants were 
separated from their infants because of 
admission to the special care nursery. 
The hospital has a rooming-in policy 
with no routine special care admissions 
after caesarean or forceps delivery. 
Fifty per cent of the women had breast 
fed or expressed within three hours of 
delivery and 85 per cent had done so 
by 24 hours. The longest interval was 
69 hours. 
In Table 2, current breast problems, 
past breast problems, breastfeeding 
history and family history are listed to 
show that the three groups were 
comparable in these respectS also. A 
high proportion of the women who 
had given birth before had suffered 
from engorgement previously (70 per 
cent), 16 per cent with episodes of 
mastitis and 29 per cent with lumps. 
Table 1 and Table 2 show that women 
referred for treatment were a small 
proportion of mothers, in whom 
breastfeeding problems were more 
likely either because of pre-term birth 
or problems in an earlier pregnancy. 
The prior breastfeeding history 
suggested that participating women 
had a strong intention to breastfeed, 
since the average duration of the , 
previous lactation was 21 weeks. 
In terms of the primary endpoints of 
the trial, the comparison was between 
ultrasound and sham treated breasts. 
Prior to treatment, the measures of 
pain and hardness in bteastsallocated 
to ultrasound were not significantly 
different to the measures in breasts 
allocated to sham treatment (Table 3). 
This was further evidence that the ' 
randomised allocation to treatment 
arms had resulted in two comparable 
groups. 
The effect of treatment is 
summarised in Table 4. Both 
ultrasound and sham treatments 
reduced pain and hardness 
significantly, using the analogue scales 
as a measure and comparing the paired 
pre-treatment and post-treatment 
ratings for each breast. 
These findings confirmed the pre-
trial experience of a subjective benefit 
with treatment and showed, in 
addition, that the improvement 
occurred with and without the 
ultrasound component. 
By contrast, the effects of treatment 
on hardness as measured by tonometry 
were small and inconsistent (Table 4). 
At the first treatment, ultrasound had a 
statistically significant effect while 
sham treatment had no detectable 
effect. At two other treatments, only 
the sham treatment had a significant 
effect. In all cases, the effect was very 
small. 
Women received from one to six 
treatments. Table 5 shows the 
distribution of these according to the 
mode of treatment, ultrasound or 
sham. There was no significant 
difference in the number of treatments 
or the dosage reading. The final 
measures of pain and hardness, once 
treatment had been concluded, were 
virtually identical in the two treatment 
groups. 
The final outcome, which was the 
duration of breastfeeding, was 
compared among the three groups 
described earlier - those in whom 
both breasts received ultrasound, those 
in whom both breasts received sham 
treatment and those in whom the 
breasts received ,different treatments. 
Three women were lost to fOllow-tIp 
and another whose baby had died Wa$ 
not contacted. The median duration of 
breastfeeding arilong the remaining 
WOmen was 18 weeks. The duration of 
breastfeeding had a bimodal 
distribution. No differences could be 
detected between the three groups 
defined above on survival analysis 
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Table 1. 
Breast problems and prior breastfeedingio the three treatment groups 
n 
Current problem(s); 
Engorgement 93 
Lumps 34 
Sore nipples 21 
Pri()r breast problems: 
Surgery· 1 
Fibrocystic disease 6 
Duration ofbreastfeeding 
Last birth (weeks]: 
<13 21 
14-26 12 
>26 25 
Reason for weaning, 
after last birth: 
Breast pain 3 
Nipple pain 2 
Reduced supply 12 
Illness (mother) 1 
(infant) 1 
Return to work 4: 
Choice (mother) 5 
(infant) 27 
Total 58 
Family history of breast 
cancer: 10 
Mother 5 
Grandmother 3 
Maternal aunt 2 
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taking into account weaning Status at 
final follow up (Chi-square test for 
homogeneity =0.09,p == 0.95; test for 
trend 0.002, p = 0.97, log rank 
method). 
Discussion 
As the two main endpoints in this 
trial were eain and hardness of the 
Ultrasound Ultrasound 
[2] [1] 
% Sham [11 Sham [2] 
[85.3] 18 55 20 
[31.2] 7 22 5 
[19.3] 7 12 2 
[0.91 0 0 1 
[5.5] 1 5 0 
[19.31 7 10 4 
[1l.0} 3 7 2 
[22.9] 4: 15 6 
[5.21 1 1 1 
13.4] 0 2 0 
[20.7J 4 4 4 
[1.7} 1 0 0 
[1.7] 0 1 0 
6.9J 2 2 0 
8.6] 1 3 1 
[46.6] 4 17 6 
[100] 
[9.2} 
[4.6] 2 3 0 
{2.S] 1 1 1 
[1.8] 0 2 0 
breasts, assessed either as subjective 
ratings or as measurements by the 
treating physiotherapist, it seemed 
essential to mask the treatment mode 
from both patient and therapist. Before 
the trial began, the physiotherapists 
expected that it would he relatively 
easy to deduce which was the real and 
which the sham treatment, hy their 
differential effectiveness, but this was 
not so. Changing labels on the two 
machines weekly was intended to 
reduce the possibility that the 
therapists would be able to identify 
which machine emitted ultrasound 
energy. 
The women who participated in the 
trial were at high risk of developing 
problems with lactation. One factor 
was a past history of breast 
engorgement. Other factors included a 
pre-term birth or a sick infant admitted 
to the special care nursery. In these 
cases, there was often a delay between 
delivery and the first feed with the 
necessity of expressing milk for the 
first few days. 
There was no evidence that operative 
delivery increased the probability of 
breast engorgement, since the 
operative delivery rates in the trial 
participants were the same as in the 
whole hospital population. 
The trial confirmed that severe breast 
engorgement is largely, but not wholly, 
preventable in a high risk perinatal 
centre. The incidence fell during the 
30 months of recruitment. 
The decision to regard each breast as 
an entry into the trial was made early 
in the planning phase as a way of 
dealing with the fact that some women 
needed treatment for one breast only. 
This meant that, in a significant 
proportion of women, ultrasound and 
sham treated breasts were closely 
matched on virtually all factors and it 
probably accounted for the degree of 
similarity on pre-treatment measures. 
Such close matching should have 
provided an ideal setting for detecting 
a real effect of ultrasound treatment. 
However, the therapists observed that 
when the analogue scales were being 
completed after treatment, it was not 
always easy for the women to make a 
clear distinction hetween left and right 
hreastsensations. . 
Our theoretical understanding of 
ultrasound .effectsand of the 
physiology of the breast initially led to 
the prediction that the henefits would 
be most apparent after hreastfeeding 
which followed soon after an 
nltrasound treatment. It was thought 
that treatment would facilitate the 
removal of milk from the engorged 
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breast by facilitating milk let-down, 
leading to less pain and hardness. 
Thus, the expected effects were of 
faster resolution (fewer treatments) and 
lower ratings of pain and hardness in 
the ultrasound treated breasts from the 
second treatment onwards. Neither of 
these was found. 
The trial demonstrated that pre-trial 
perceptions of the effectiveness of 
treatment were correct, but it was also 
able to show that effective treatment 
did not depend on the ultrasound 
component. Further evidence for this 
placebo effect came from the 
difference between subjective ratings 
of hardness and tonometric readings. 
The subjective ratings improved 15 to 
30 per cent with treatment, while the 
average quadrant tonometer readings 
scarcely altered at all. 
The components which might have 
contributed to a therapeutic effect 
were listed in the introduction as 
warmth, rest, massage, attention and 
the emotional, practical, and 
informational support provided by the 
physiotherapists in the course of 
treatment. 
To these should perhaps be added the 
perceived benefit of being the recipient 
of modem technology. 
These findings are very similar to 
those reported from a recent placebo-
controlled trial of ultrasound and 
pulsed electromagnetic energy 
treatment for perineal trauma (Grant 
et aI1989). In that trial, 90 per cent of 
women in all groups thought the 
treatment had done some good, but 
there were no significant differences 
between the ultrasound, the pulsed 
electromagnetic energy and the 
placebo groups. 
The two trials support the strength of 
the placebo theory of the perceived 
effects of treatment by machine. 
Although it is possible that lower or 
higher dosages of ultrasound, different 
durations of treatment or the use of 
pulsed instead of continuous wave 
might have a therapeutic effect beyond 
the placebo effects detected in this 
trial, the treatment details selected 
were those which, having been in use 
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Table 3. 
Pre-treabnent measures of pain and hardness in ultrasound and sham treated 
breasts. 
Pre-treatment scores 
1st 2nd 300 
(SEM) (SEM) (SEM) 
1. Pain (analog scale) 
Ultrasound 36.8 (2.4) 32.0 (2.8) 23.1 (2.5) 
Sham 41.6 (2.6) 30.6 (2.7) 23.8 (3.1) 
2. Hardness (analog scale) 
Ultrasound 72.1 (2.0) 55.6 (2.5) 42.3 (3.1) 
Sham 74.0 (2.3) 54.4 (3.1) 48.4(3.9) 
3. Hardness (tonometry*) 
Ultrasound 31.0 (1.4) 28.8 (1.6) 29.1 (1.7) 
Sham 29.7 (1.4) 28.5 (1.7) 28.4 (1.8) 
Mean score *mean of the four quadrant scores 
SEM standard error of the mean 
4th 
(SEM) 
18.7 (3.4) 
18.2 (3.5) 
32.5 (4.2) 
35.6 (4.7) 
28.2 (2.2) 
27.6 (2.4) 
5th 
(SEM) 
13.8 (3.2) 
20.5 (4.3) 
26.1 (5.6) 
34.7 (7.4) 
24.1 (3.0) 
25.1 (2.9) 
No differences between ultrasound and sham-treated breasts were statistically 
significant. 
Table4. 
The effect of treatment on measures of pain and hardness in uhrasound and sham-
treated breasts. 
Treatment number 
1st 2nd 3rd 
d (SE.M) d(SEM) d(SEM) 
1. Pain (analog scale) 
Ultrasound 4.4 (1.7)2 5.1 (1.4) 4.5 (1.3) 
Sham 8.4 (1.8)' 8.6 (1.7)' 2.8 (1.4Y 
2. Hardness (analog scale) 
Ultrasound 10.4 (1.9)' 6.6 (1.5)' 6.8 (1.4)' 
Sham 11.8 (2.2)' 8.8 (1.7)' 8.2 (1.4)' 
3. Hardness (tonometry) 
Ultrasound 1.27 (0.41) 10.25 (0.57) 0.70 (1.01) 
Sham 0.46 (0.70) 1.40 (0.47)2 1.21 (0.60) 
d mean of the paired differences, pre-post treatment 
SEM standard error of mean 
1. Z > 3.10 
2. z> 2.57 
3. z > 1.65 
p<o.OOl 
p<0.005 
p<0.05 
4th 5th 
d(SEM) d(SEM) 
3.2 (1.9)J 3.4 (1.8)J 
2.7 (1.7)3 6.8 (3.2)J 
4.5 (2.0)3 3.9 (1.6)3 
6.1 (2.1)2 8.5 (4.7)3 
0.58 (0.85) -0.9J (1.44) 
1.21 (0.60) 2.05 (1.64) 
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in the hospital and elsewhere for the 
two years prior to the trial, had been 
found to be clinically effective. 
The trial could not detect an 
objective beneficial effect of ultrasound 
on breast engorgement. It is obvious 
that more controlled trials are needed 
to test modifications of dosage, e.g. 
pulsed ultrasound and its effect on 
other physiological conditions of the 
breast, e.g. unresolved lumps and 
mastitis. Given the evidence in this 
trial and in the trial reported by Grant 
et al (1989) dealing with perineal 
trauma, it is essential for future trials to 
be double blind and placebo 
controlled. 
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Table 5. 
A comparison of ultrasound tr~ated and sham-treated breasts. 
n 
Left breast 94 
Right breast 103 
Number of treatments: 
X2 = 1.26 p>0.9 
Dosage Watts/cm2 
Final measures 
Pain (analog scale) 
Hardness (analog scale) 
Hardness (tonometry) 
X mean 
SEM standard error of mean. 
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Ultrasound 
n 
53 
57 
7 
25 
36 
22 
18 
2 
2.4-2.6 
X(SEM) 
13.0 (2.5) 
22.3 (2.3) 
21.4(1.3) 
Sham 
n 
41 
46 
6 
23 
23 
20 
13 
2 
2.4-2.6 
X(SEM) 
13.0 (2.3) 
23.7 (2.7) 
19.7 (L6) 
